PetMed Express Hits 52-Week Low at $2.71 Amidst Yearly Decline

PetMed Express, Inc., a microcap company in the retailing industry, has reached a new 52-week low of USD 2.71 as of September 19, 2025. This decline marks a significant downturn for the stock, which has experienced a 35% decrease in value over the past year, contrasting sharply with the S&P 500's performance of 16.64% during the same period.
The company's market capitalization stands at USD 59 million, and it currently has a price-to-earnings (P/E) ratio of 82.00. Notably, PetMed Express has a debt-to-equity ratio of -0.52, indicating a strong balance sheet with minimal debt. However, its return on equity (ROE) is relatively low at 0.29%, and the price-to-book ratio is 0.61, suggesting that the stock may be undervalued compared to its book value.

Despite the recent price drop, PetMed Express has shown a remarkable profit increase of 104.7% over the past year, although it has consistently underperformed against the S&P 500 over the last three years. The company's dividend yield remains at 0.00%, reflecting its current focus on growth rather than returning capital to shareholders.